Compare Novo Nordisk A/S (NVO) vs Rockwell Automation (ROK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Rockwell Automation — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Rockwell Automation trades at $466.2 (market cap $51.04B). The key difference: Novo Nordisk A/S is far larger — about 4.3× Rockwell Automation's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| NVO | ROK | |
|---|---|---|
Market Cap | $220.53B | $51.04B |
Sector | Health | Industrials |
52-Week High | $71.70 | $495.08 |
52-Week Low | $35.29 | $328.67 |
Enterprise Value | $239.49B | $54.67B |
Dividend Yield | 3.63% | 1.2% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Rockwell Automation
Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →
